Zacks Initiates Coverage of Palladyne AI With Neutral Recommendation
Zacks Investment Research has recently initiated coverage of Palladyne AI Corp. PDYN with a Neutral recommendation, reflecting a balanced view of the company's emerging opportunities and ongoing operational challenges. Palladyne AI, headquartered in Salt Lake City, UT, is developing edge-based artificial intelligence software that enables drones and robotic systems to operate autonomously without relying on centralized infrastructure, a technology that has drawn attention in both defense and industrial sectors.
The company's flagship platform, Palladyne Pilot, became commercially available in the second quarter of 2025. This marks a key milestone for Palladyne AI, validating its core AI/ML technology through successful real-world deployments. The software enables real-time collaboration among drones using multi-modal sensor data and is designed to function independently of cloud connectivity, making it particularly well-suited for defense scenarios. A $26 million-plus U.S. Air Force contract awarded is helping to transition the platform to U.S.-made chipsets, enhancing compatibility with government procurement standards and national security objectives.
Palladyne AI's liquidity position is another area of strength, as highlighted in the research report. As of March 31, 2025, the company held $46.6 million in cash and marketable securities, up from $40.1 million at the end of 2024. This was supported by successful equity raises totaling $39.4 million across the last two quarters, giving Palladyne AI the financial flexibility to support continued product development and go-to-market execution. Meanwhile, the company's AI software is hardware-agnostic, positioning it to serve a broader addressable market that spans industrial robots, unmanned aerial vehicles (UAVs), and ground-based robotics.
Revenue in the first quarter of 2025 rose 94% year over year to $1.7 million, driven by defense-related development contracts. Operating expenses declined 20% from the prior year, reflecting improved cost discipline and helping to manage cash burn. These trends indicate management's commitment to capital efficiency as it transitions from a contract development model toward commercial software licensing.
However, several concerns prevail for the company, as outlined in the report. Despite the commercial availability of its software, Palladyne AI has not yet recorded any product revenue in 2025. The entire revenue base still comes from non-recurring development contracts, leaving questions about the company's ability to scale licensing deals. Its backlog remains limited at $1.9 million, with only a portion of it funded.
In addition, Palladyne AI operates in an increasingly competitive market. Large industrial players such as ABB and Fanuc are investing heavily in AI-driven robotics, bringing scale, global reach, and established customer bases. Palladyne AI's exclusive focus on the U.S. market may limit its exposure to faster-growing international regions and leave it vulnerable to fluctuations in domestic government spending.
Palladyne's share price has been volatile, reflecting investor enthusiasm for its edge-based AI platform as well as uncertainty around its financial sustainability. The company's valuation metrics appear elevated relative to peers, which may limit near-term upside potential.
Palladyne's performance is supported by strong government backing, solid liquidity, early traction in defense R&D, and a scalable, hardware-agnostic software platform. However, the absence of recurring revenue, persistent operating losses, a small backlog, intensifying competition, and geographic concentration remain key headwinds. For a comprehensive look at the company's growth drivers and risk factors, read the full Zacks Investment Research report on PDYN.
Read the full Research Report on Palladyne AI here>>>
Note: Our initiation of coverage on Palladyne AI, which has a modest market capitalization of $257.7 million, aims to equip investors with the information needed to make informed decisions in this promising but inherently risky segment of the market.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Palladyne AI Corp. (PDYN) : Free Stock Analysis Report
This article originally published on Zacks Investment Research (zacks.com).
Zacks Investment Research
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
NIO Expects Y/Y Rise in Q2 Deliveries: What are the Growth Agents?
NIO Inc. NIO introduced upgraded versions of four key models, the EC6, ES6, ET5, and ET5T, at the end of May and has recently started deliveries of all four. These models are expected to see their first full month of deliveries in June. On the strength of these new launches, NIO anticipates a year-over-year rise in both June and second-quarter deliveries. The company expects June deliveries in the range of 25,000 and 28,000 units, up from 21,209 units in the same month last year. For the second quarter, NIO expects to deliver between 72,000 and 75,000 vehicles, indicating a 25.5% to 30.7% year-over-year the first quarter of 2025, NIO delivered a total of 42,094 smart EVs, representing a 40.1% year-over-year increase. The deliveries include 27,313 units under the NIO brand and 14,781 from ONVO. Since the beginning of the second quarter, deliveries have gained momentum, driven by the initial rollout of the ET9 and FIREFLY models as well as strong demand for the ONVO L60. FIREFLY is a smart electric high-end small car brand for which deliveries started in late April. NIO carries a Zacks Rank #3 (Hold) at present. You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks local competitors, Li Auto Inc. LI & XPeng Inc. XPEV, also expect year-over-year growth in second quarter deliveries. Li Auto expects its vehicle deliveries for the second quarter of 2025 to range between 123,000 and 128,000 units, indicating year-over-year growth of 13.3% to 17.9%. In the first quarter of 2025, the company delivered 92,864 units, up 15.5% compared to the same period last year. Over the past month, Li Auto has completed a full upgrade of its entire vehicle lineup, introducing updated versions across all expects to deliver around 102,000 and 108,000 vehicles in the second quarter of 2025, indicating year-over-year growth of approximately 237.7% to 257.5%. In the first quarter, XPeng delivered 94,008 units, up 330.8% from 21,821 vehicles delivered during the same period in 2024. NIO has underperformed the Zacks Automotive-Domestic industry year to date. NIO shares have lost 30.1% compared to the industry's growth of 4.1%. Image Source: Zacks Investment Research From a valuation perspective, NIO appears overvalued. Going by its price/sales ratio, the company is trading at a forward sales multiple of 0.81, higher than its industry's 0.50. Image Source: Zacks Investment Research The Zacks Consensus Estimate for 2025 and 2026 EPS has moved up 5 cents and declined by a penny, respectively, in the past seven days. Image Source: Zacks Investment Research Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report NIO Inc. (NIO) : Free Stock Analysis Report Li Auto Inc. Sponsored ADR (LI) : Free Stock Analysis Report XPeng Inc. Sponsored ADR (XPEV) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research
Yahoo
2 hours ago
- Yahoo
Here's Why AutoNation (AN) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Many investors also have a go-to methodology that helps guide their buy and sell decisions. One way to find winning stocks based on your preferred way of investing is to use the Zacks Style Scores, which are indicators that rate stocks based on three widely-followed investing types: value, growth, and momentum. Different than growth or momentum investors, value-focused investors are all about finding good stocks at good prices, and discovering which companies are trading under what their true value is before the broader market catches on. The Value Style Score utilizes ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to help pick out the most attractive and discounted stocks. AutoNation, Inc. is one of the largest automotive retailers in the United States. Apart from retailing new and used vehicles, the company offers vehicle maintenance and repair services, vehicle parts, extended service contracts, vehicle protection products, and other aftermarket products. In addition, it arranges financing for vehicle purchases through third-party sources. AN is a Zacks Rank #3 (Hold) stock, with a Value Style Score of A and VGM Score of A. Shares are currently trading at a forward P/E of 10X for the current fiscal year compared to the Automotive - Retail and Whole Sales industry's P/E of 10.7X. Additionally, AN has a PEG Ratio of 1 and a Price/Cash Flow ratio of 7.7X. Value investors should also note AN's Price/Sales ratio of 0.3X. Many value investors pay close attention to a company's earnings as well. For AN, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.43 to $18.67 per share for 2025. Per share AN boasts an average earnings surprise of 1.6%. AN should be on investors' short lists because of its impressive earnings and valuation fundamentals, a good Zacks Rank, and strong Value and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AutoNation, Inc. (AN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Here's Why GSK (GSK) is a Strong Value Stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Achieving those goals is made easier with the Zacks Style Scores, a unique set of guidelines that rates stocks based on popular investing methodologies, namely value, growth, and momentum. The Style Scores can help you narrow down which stocks are better for your portfolio and which ones can beat the market over the long-term. Finding good stocks at good prices, and discovering which companies are trading under their true value, are what value investors like to focus on. So, the Value Style Score takes into account ratios like P/E, PEG, Price/Sales, and Price/Cash Flow to highlight the most attractive and discounted stocks. GSK has three segments: Specialty Medicines (HIV, Oncology, Immunology/Respiratory and Other), Vaccines (Meningitis, Influenza, Shingles, RSV and Established Vaccines) and General Medicines (Respiratory and Other), which are clubbed as commercial operations. GSK boasts a Value Style Score of A and VGM Score of B, and holds a Zacks Rank #2 (Buy) rating. Shares of GSK are trading at a forward earnings multiple of 9.5X, as well as a PEG Ratio of 1.6, a Price/Cash Flow ratio of 7.4X, and a Price/Sales ratio of 2.1X. Many value investors pay close attention to a company's earnings as well. For GSK, five analysts revised their earnings estimate upwards in the last 60 days, and the Zacks Consensus Estimate has increased $0.12 to $4.32 per share for 2025. Per share GSK boasts an average earnings surprise of 8.6%. Investors should take the time to consider GSK for their portfolios due to its solid Zacks Ranks, notable earnings and valuation metrics, and impressive Value and VGM Style Scores. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report GSK PLC Sponsored ADR (GSK) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
